2578319-11-4
2578319-11-4
Chemical Structure
Bebtelovimab
Synonym(s): LY-3853113; LY-COV1404
- CAS No.: 2578319-11-4
- Formula:N/A
- Molecular Weight:(143.82 kDa)
IUPAC Name: ethyl 1-(2-amino-4-(4-chlorothiophen-2-yl)thiazol-5-yl)piperidine-4-carboxylate
SMILES: [Bebtelovimab]
Biological Activity: Bebtelovimab a human IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19 ((the IC50 value for SARS-CoV-2/MT020880.1 virus is 9-22.1 ng/mL)). Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bebtelovimab | 97.41% | Bebtelovimab a human IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19 ((the IC50 value for SARS-CoV-2/MT020880.1 virus is 9-22.1 ng/mL)). Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
